Genetic determinants of risk and progression in multiple sclerosis

Clinica Chimica Acta

Volumn 449, Issue , 2015, Pages 16-22

  Didonna, Alessandro ^a   Oksenberg, Jorge R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Complex disease; GWAS; Multiple sclerosis; Risk variant

Indexed keywords

LEUKOCYTE ANTIGEN;

ARTICLE; AUTOIMMUNITY; DISEASE COURSE; DISEASE SEVERITY; GENE; GENE CLUSTER; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC VARIABILITY; GENOTYPE; HLA DRB1 GENE; HLA GENE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX;

DISEASE PROGRESSION; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS;

EID: 84940440134     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.01.034     Document Type: Article

References (101)

1. Hauser S.L., Goodin D.S. Multiple sclerosis and other demyelinating diseases. Harrison's principle of internal medicine 2012, McGraw-Hill. 18th Edition.
2. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
3. Koch-Henriksen N., Sorensen P.S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010, 9:520-532.
4. Simpson S., Blizzard L., Otahal P., Van der Mei I., Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011, 82:1132-1141.
5. Pugliatti M., Sotgiu S., Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002, 104:182-191.
6. Sadovnick A.D., Baird P.A. The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology 1988, 38:990-991.
7. Robertson N.P., Fraser M., Deans J., Clayton D., Walker N., Compston D.A. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996, 119:449-455.
8. Willer C.J., Dyment D.A., Risch N.J., Sadovnick A.D., Ebers G.C., Canadian Collaborative Study Group Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 2003, 100:12877-12882.
9. Ebers G.C., Sadovnick A.D., Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995, 377:150-151.
10. Ebers G.C., Yee I.M., Sadovnick A.D., Duquette P. Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Canadian Collaborative Study Group. Ann Neurol 2000, 48:927-931.
11. Simon K.C., Munger K.L., Ascherio A. XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?. J Neurol Sci 2011, 311:1-8.
12. Huynh J.L., Casaccia P. Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment. Lancet Neurol 2013, 12:195-206.
13. Detels R., Visscher B.R., Malmgren R.M., Coulson A.H., Lucia M.V., Dudley J.P. Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans. Am J Epidemiol 1977, 105:303-310.
14. Cree B.A., Khan O., Bourdette D., et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004, 63:2039-2045.
15. Wallin M.T., Page W.F., Kurtzke J.F. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 2004, 55:65-71.
16. Wallin M.T., Culpepper W.J., Coffman P., et al. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain 2012, 135:1778-1785.
17. Langer-Gould A., Brara S.M., Beaber B.E., Zhang J.L. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology 2013, 80:1734-1739.
18. Hader W.J. Prevalence of multiple sclerosis in Saskatoon. Can Med Assoc J 1982, 127:295-297.
19. Svenson L.W., Woodhead S.E., Platt G.H. Regional variations in the prevalence rates of multiple sclerosis in the province of Alberta, Canada. Neuroepidemiology 1994, 13:8-13.
20. Cocco E., Sardu C., Massa R., et al. Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler 2011, 17:1282-1289.
21. Cree B.A., Reich D.E., Khan O., et al. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch Neurol 2009, 66:226-233.
22. Boster A.L., Endress C.F., Hreha S.A., Caon C., Perumal J.S., Khan O.A. Pediatric-onset multiple sclerosis in African-American black and European-origin white patients. Pediatr Neurol 2009, 40:31-33.
23. Chakravarti A. Population genetics-making sense out of sequence. Nat Genet 1999, 21:56-60.
24. O'Gorman C., Lin R., Stankovich J., Broadley S.A. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology 2013, 40:1-12.
25. Barrett J.C., Clayton D.G., Concannon P., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.
26. Gorer P.A. The detection of a hereditary antigenic difference in the blood of mice by means of human group A serum. J Genet 1936, 32:17-31.
27. The MHC sequencing consortium Complete sequence and gene map of a human major histocompatibility complex. Nature 1999, 401:921-923.
28. Petersdorf E.W. The major histocompatibility complex: a model for understanding graft-versus-host disease. Blood 2013, 122:1863-1872.
29. Tsai S., Santamaria P. MHC class II polymorphisms, autoreactive T-cells, and autoimmunity. Front Immunol 2013, 4:321.
30. Oksenberg J.R., Barcellos L.F., Cree B.A., et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004, 74:160-167.
31. Qiu W., James I., Carroll W.M., Mastaglia F.L., Kermode A.G. HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis. Mult Scler 2011, 17:382-388.
32. McElroy J.P., Isobe N., Gourraud P.A., et al. SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. Genes Immun 2011, 12:523-530.
33. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2 Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
34. Isobe N., Gourraud P.A., Harbo H.F., et al. Genetic risk variants in African Americans with multiple sclerosis. Neurology 2013, 81:219-227.
35. International MHC and Autoimmunity Genetics Network Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A 2009, 106:18680-18685.
36. Patsopoulos N.A., Barcellos L.F., Hintzen R.Q., et al. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet 2013, 9:e1003926.
37. Yoshimura S., Isobe N., Yonekawa T., et al. Genetic and infectious profiles of Japanese multiple sclerosis patients. PLoS One 2012, 7:e48592.
38. Willer C.J., Dyment D.A., Cherny S., et al. A genome-wide scan in forty large pedigrees with multiple sclerosis. J Hum Genet 2007, 52:955-962.
39. Sawcer S., Ban M., Maranian M., et al. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005, 77:454-467.
40. Hardy J., Singleton A. Genomewide association studies and human disease. N Engl J Med 2009, 360:1759-1768.
41. Hirschhorn J.N., Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005, 6:95-108.
42. International Multiple Sclerosis Genetics Consortium Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007, 357:851-862.
43. International Multiple Sclerosis Genetics Consortium Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013, 45:1353-1360.
44. Baranzini S.E., Srinivasan R., Khankhanian P., et al. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 2010, 133:2603-2611.
45. Gourraud P.A., Sdika M., Khankhanian P., et al. A genome-wide association study of brain lesion distribution in multiple sclerosis. Brain 2013, 136:1012-1024.
46. Azevedo C.J., Kornak J., Chu P., et al. In vivo evidence of glutamate toxicity in multiple sclerosis. Ann Neurol 2014, 76:269-278.
47. Zuk O., Hechter E., Sunyaev S.R., Lander E.S. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 2012, 109:1193-1198.
48. Hunt K.A., Mistry V., Bockett N.A., et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 2013, 498:232-235.
49. Maurano M.T., Humbert R., Rynes E., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
50. Gregory S.G., Schmidt S., Seth P., et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007, 39:1083-1091.
51. Gregory A.P., Dendrou C.A., Attfield K.E., et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012, 488:508-511.
52. Couturier N., Bucciarelli F., Nurtdinov R.N., et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 2011, 134:693-703.
53. Sturner K.H., Borgmeyer U., Schulze C., Pless O., Martin R. A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function. J Immunol 2014, 193:4439-4447.
54. Tishkoff S.A., Kidd K.K. Implications of biogeography of human populations for 'race' and medicine. Nat Genet 2004, 36:S21-S27.
55. Kantor D.B., Palmer C.D., Young T.R., et al. Replication and fine mapping of asthma-associated loci in individuals of African ancestry. Hum Genet 2013, 132:1039-1047.
56. Gong J., Schumacher F., Lim U., et al. Fine mapping and identification of BMI loci in African Americans. Am J Hum Genet 2013, 93:661-671.
57. Miller S.D., Karpus W.J., Davidson T.S. Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol 2010, 1-20. [Chapter 15, Unit 15.1].
58. Attfield K.E., Dendrou C.A., Fugger L. Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis. Immunol Rev 2012, 248:10-22.
59. Weissert R., Wallstrom E., Storch M.K., et al. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 1998, 102:1265-1273.
60. Blankenhorn E.P., Butterfield R., Case L.K., et al. Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis. Ann Neurol 2011, 70:887-896.
61. Sundvall M., Jirholt J., Yang H.T., et al. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet 1995, 10:313-317.
62. Gregersen J.W., Kranc K.R., Ke X., et al. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 2006, 443:574-577.
63. Kaushansky N., Altmann D.M., David C.S., Lassmann H., Ben-Nun A. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP). J Neuroinflammation 2012, 9:29.
64. Friese M.A., Jakobsen K.B., Friis L., et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med 2008, 14:1227-1235.
65. Harris T.J., Grosso J.F., Yen H.R., et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 2007, 179:4313-4317.
66. Suvannavejh G.C., Lee H.O., Padilla J., Dal Canto M.C., Barrett T.A., Miller S.D. Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cell Immunol 2000, 205:24-33.
67. Schraml B.U., Hildner K., Ise W., et al. The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 2009, 460:405-409.
68. Ashbaugh J.J., Brambilla R., Karmally S.A., Cabello C., Malek T.R., Bethea J.R. IL7Ralpha contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages. J Immunol 2013, 190:4525-4534.
69. Brassat D., Azais-Vuillemin C., Yaouanq J., et al. Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group. Neurology 1999, 52:1632-1636.
70. Barcellos L.F., Oksenberg J.R., Green A.J., et al. Genetic basis for clinical expression in multiple sclerosis. Brain 2002, 125:150-158.
71. Hensiek A.E., Seaman S.R., Barcellos L.F., et al. Familial effects on the clinical course of multiple sclerosis. Neurology 2007, 68:376-383.
72. Wellek A., Korsukewitz C., Bach J.P., et al. Sibling disability risk at onset and during disease progression in familial multiple sclerosis. Mult Scler 2011, 17:1060-1066.
73. Butterfield R.J., Blankenhorn E.P., Roper R.J., Zachary J.F., Doerge R.W., Teuscher C. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol 2000, 157:637-645.
74. Marta M., Stridh P., Becanovic K., et al. Multiple loci comprising immune-related genes regulate experimental neuroinflammation. Genes Immun 2010, 11:21-36.
75. Thessen Hedreul M., Moller S., Stridh P., et al. Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity. Hum Mol Genet 2013, 22:4952-4966.
76. Laaksonen H., Guerreiro-Cacais A.O., Adzemovic M.Z., et al. The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation. Genes Immun 2014, 15:457-465.
77. Healy B.C., Liguori M., Tran D., et al. HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology 2010, 75:634-640.
78. Qiu W., Raven S., James I., et al. Spinal cord involvement in multiple sclerosis: a correlative MRI and high-resolution HLA-DRB1 genotyping study. J Neurol Sci 2011, 300:114-119.
79. Okuda D.T., Srinivasan R., Oksenberg J.R., et al. Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 2009, 132:250-259.
80. Masterman T., Ligers A., Olsson T., Andersson M., Olerup O., Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000, 48:211-219.
81. Smestad C., Brynedal B., Jonasdottir G., et al. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol 2007, 14:835-840.
82. Harbo H.F., Isobe N., Berg-Hansen P., et al. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler 2014, 20:660-668.
83. Sharan S.K., Thomason L.C., Kuznetsov S.G., Court D.L. Recombineering: a homologous recombination-based method of genetic engineering. Nat Protoc 2009, 4:206-223.
84. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007, 39:1329-1337.
85. Comabella M., Craig D.W., Camina-Tato M., et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One 2008, 3:e3490.
86. Aulchenko Y.S., Hoppenbrouwers I.A., Ramagopalan S.V., et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 2008, 40:1402-1403.
87. Baranzini S.E., Wang J., Gibson R.A., et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009, 18:767-778.
88. De Jager P.L., Jia X., Wang J., et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009, 41:776-782.
89. Australia, New Zealand Multiple Sclerosis Genetics Consortium Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009, 41:824-828.
90. Sanna S., Pitzalis M., Zoledziewska M., et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 2010, 42:495-497.
91. Nischwitz S., Cepok S., Kroner A., et al. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol 2010, 227:162-166.
92. Jakkula E., Leppa V., Sulonen A.M., et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010, 86:285-291.
93. Patsopoulos N.A., Bayer Pharma MSGWG, Steering Committees of Studies Evaluating Interferon-b, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011, 70:897-912.
94. Matesanz F., Gonzalez-Perez A., Lucas M., et al. Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PLoS One 2012, 7:e36140.
95. Martinelli-Boneschi F., Esposito F., Brambilla P., et al. A genome-wide association study in progressive multiple sclerosis. Mult Scler 2012, 18:1384-1394.
96. Maier L.M., Lowe C.E., Cooper J., et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet 2009, 5:e1000322.
97. De Jager P.L., Baecher-Allan C., Maier L.M., et al. The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci U S A 2009, 106:5264-5269.
98. Kofler D.M., Severson C.A., Mousissian N., De Jager P.L., Hafler D.A. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation. J Immunol 2011, 187:3286-3291.
99. Martin D., Pantoja C., Fernandez Minan A., et al. Genome-wide CTCF distribution in vertebrates defines equivalent sites that aid the identification of disease-associated genes. Nat Struct Mol Biol 2011, 18:708-714.
100. Shahijanian F., Parnell G.P., McKay F.C., et al. The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells. Hum Mol Genet 2014, 23:1425-1434.
101. Paraboschi E.M., Rimoldi V., Solda G., et al. Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. Hum Mol Genet 2014, 23:6746-6761.